Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Some plans cover GLP-1 medications
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related conditions (Zepbound)
GCGR, Glucagon receptor
If you've achieved your weight loss goals and want support to keep the weight off, we can continue providing treatment
US$ 20.39
.webp)
US$ 21.32
US$ 27.33
&srotate=0)
US$ 26.99
US$ 25.12
US$ 21.69
US$ 23.45
US$ 23.50
